Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3121 to 3126 of 3126 entries
Sorted by: Best Match Show Resources per page
Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation.

International journal of molecular sciences

Kim JS, Choi SW, Park YG, Kim SJ, Choi CH, Cha MJ, Chang JH.
PMID: 35008778
Int J Mol Sci. 2021 Dec 29;23(1). doi: 10.3390/ijms23010351.

Cardiac radioablation is emerging as an alternative option for refractory ventricular arrhythmias. However, the immediate acute effect of high-dose irradiation on human cardiomyocytes remains poorly known. We measured the electrical activities of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)...

Cite
Kim JS, Choi SW, Park YG, et al. Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010351.
Kim, J. S., Choi, S. W., Park, Y. G., Kim, S. J., Choi, C. H., Cha, M. J., & Chang, J. H. (2021). Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010351
Kim, Jae Sik, et al. "Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010351
Kim JS, Choi SW, Park YG, Kim SJ, Choi CH, Cha MJ, Chang JH. Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation. Int J Mol Sci. 2021 Dec 29;23(1). doi: 10.3390/ijms23010351. PMID: 35008778.
Copy Download .nbib Format: NLM
Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model.

International journal of molecular sciences

Fang CH, Sun CK, Lin YW, Hung MC, Lin HY, Li CH, Lin IP, Chang HC, Sun JS, Chang JZ.
PMID: 35008984
Int J Mol Sci. 2022 Jan 05;23(1). doi: 10.3390/ijms23010558.

In this study, we fabricated gelatin/nano-hydroxyapatite/metformin scaffold (GHMS) and compared its effectiveness in bone regeneration with extraction-only, Sinbone, and Bio-Oss Collagen

Cite
Fang CH, Sun CK, Lin YW, et al. Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model. Int J Mol Sci. 2022;23(1)doi: 10.3390/ijms23010558.
Fang, C. H., Sun, C. K., Lin, Y. W., Hung, M. C., Lin, H. Y., Li, C. H., Lin, I. P., Chang, H. C., Sun, J. S., & Chang, J. Z. (2022). Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010558
Fang, Chih-Hsiang, et al. "Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model." International journal of molecular sciences vol. 23,1 (2022). doi: https://doi.org/10.3390/ijms23010558
Fang CH, Sun CK, Lin YW, Hung MC, Lin HY, Li CH, Lin IP, Chang HC, Sun JS, Chang JZ. Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model. Int J Mol Sci. 2022 Jan 05;23(1). doi: 10.3390/ijms23010558. PMID: 35008984.
Copy Download .nbib Format: NLM
Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study.

Cancer medicine

Hwang K, Kim J, Kang SG, Jung TY, Kim JH, Kim SH, Kang SH, Hong YK, Kim TM, Kim YJ, Choi BS, Chang JH, Kim CY.
PMID: 34845868
Cancer Med. 2022 Jan;11(2):371-379. doi: 10.1002/cam4.4454. Epub 2021 Nov 30.

BACKGROUND: An open-label single-arm phase 2 study was conducted to evaluate the role of levetiracetam as a sensitizer of concurrent chemoradiotherapy (CCRT) for patients with newly diagnosed glioblastoma. This study aimed to determine the survival benefit of levetiracetam in...

Cite
Hwang K, Kim J, Kang SG, et al. Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study. Cancer Med. 2021;11(2):371-379doi: 10.1002/cam4.4454.
Hwang, K., Kim, J., Kang, S. G., Jung, T. Y., Kim, J. H., Kim, S. H., Kang, S. H., Hong, Y. K., Kim, T. M., Kim, Y. J., Choi, B. S., Chang, J. H., & Kim, C. Y. (2022). Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study. Cancer medicine, 11(2), 371-379. https://doi.org/10.1002/cam4.4454
Hwang, Kihwan, et al. "Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study." Cancer medicine vol. 11,2 (2022): 371-379. doi: https://doi.org/10.1002/cam4.4454
Hwang K, Kim J, Kang SG, Jung TY, Kim JH, Kim SH, Kang SH, Hong YK, Kim TM, Kim YJ, Choi BS, Chang JH, Kim CY. Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study. Cancer Med. 2022 Jan;11(2):371-379. doi: 10.1002/cam4.4454. Epub 2021 Nov 30. PMID: 34845868; PMCID: PMC8729048.
Copy Download .nbib Format: NLM
Technology of deep brain stimulation: current status and future directions.

Nature reviews. Neurology

Krauss JK, Lipsman N, Aziz T, Boutet A, Brown P, Chang JW, Davidson B, Grill WM, Hariz MI, Horn A, Schulder M, Mammis A, Tass PA, Volkmann J, Lozano AM.
PMID: 33244188
Nat Rev Neurol. 2021 Feb;17(2):75-87. doi: 10.1038/s41582-020-00426-z. Epub 2020 Nov 26.

Deep brain stimulation (DBS) is a neurosurgical procedure that allows targeted circuit-based neuromodulation. DBS is a standard of care in Parkinson disease, essential tremor and dystonia, and is also under active investigation for other conditions linked to pathological circuitry,...

Cite
Krauss JK, Lipsman N, Aziz T, et al. Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol. 2020;17(2):75-87doi: 10.1038/s41582-020-00426-z.
Krauss, J. K., Lipsman, N., Aziz, T., Boutet, A., Brown, P., Chang, J. W., Davidson, B., Grill, W. M., Hariz, M. I., Horn, A., Schulder, M., Mammis, A., Tass, P. A., Volkmann, J., & Lozano, A. M. (2021). Technology of deep brain stimulation: current status and future directions. Nature reviews. Neurology, 17(2), 75-87. https://doi.org/10.1038/s41582-020-00426-z
Krauss, Joachim K, et al. "Technology of deep brain stimulation: current status and future directions." Nature reviews. Neurology vol. 17,2 (2021): 75-87. doi: https://doi.org/10.1038/s41582-020-00426-z
Krauss JK, Lipsman N, Aziz T, Boutet A, Brown P, Chang JW, Davidson B, Grill WM, Hariz MI, Horn A, Schulder M, Mammis A, Tass PA, Volkmann J, Lozano AM. Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol. 2021 Feb;17(2):75-87. doi: 10.1038/s41582-020-00426-z. Epub 2020 Nov 26. PMID: 33244188; PMCID: PMC7116699.
Copy Download .nbib Format: NLM
Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence.

Infection and drug resistance

Jian MJ, Chung HY, Chang CK, Lin JC, Yeh KM, Chen CW, Li SY, Hsieh SS, Liu MT, Yang JR, Tang SH, Perng CL, Chang FY, Shang HS.
PMID: 34429623
Infect Drug Resist. 2021 Aug 17;14:3255-3261. doi: 10.2147/IDR.S328327. eCollection 2021.

PURPOSE: Accurate molecular diagnostic assays for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, are needed for epidemiology studies and to support infection-control measures. We evaluated the analytical sensitivity and clinical performance of three...

Cite
Jian MJ, Chung HY, Chang CK, et al. Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence. Infect Drug Resist. 2021;14:3255-3261doi: 10.2147/IDR.S328327.
Jian, M. J., Chung, H. Y., Chang, C. K., Lin, J. C., Yeh, K. M., Chen, C. W., Li, S. Y., Hsieh, S. S., Liu, M. T., Yang, J. R., Tang, S. H., Perng, C. L., Chang, F. Y., & Shang, H. S. (2021). Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence. Infection and drug resistance, 143255-3261. https://doi.org/10.2147/IDR.S328327
Jian, Ming-Jr, et al. "Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence." Infection and drug resistance vol. 14 (2021): 3255-3261. doi: https://doi.org/10.2147/IDR.S328327
Jian MJ, Chung HY, Chang CK, Lin JC, Yeh KM, Chen CW, Li SY, Hsieh SS, Liu MT, Yang JR, Tang SH, Perng CL, Chang FY, Shang HS. Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence. Infect Drug Resist. 2021 Aug 17;14:3255-3261. doi: 10.2147/IDR.S328327. eCollection 2021. PMID: 34429623; PMCID: PMC8380303.
Copy Download .nbib Format: NLM
Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea.

Clinical laboratory

Kim YJ, Jung HW, Choi YS, Chang HK, Kim SH, Yeo SG.
PMID: 35023671
Clin Lab. 2022 Jan 01;68(1). doi: 10.7754/Clin.Lab.2021.210507.

BACKGROUND: Recently, microbiome of otitis media with effusion (OME) was investigated using high throughput sequencing (HTS) in children to discover unbiased causal bacteria and natural otitis media microbiomes. However, there are very few studies in the Asian population, and...

Cite
Kim YJ, Jung HW, Choi YS, et al. Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea. Clin Lab. 2022;68(1)doi: 10.7754/Clin.Lab.2021.210507.
Kim, Y. J., Jung, H. W., Choi, Y. S., Chang, H. K., Kim, S. H., & Yeo, S. G. (2022). Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea. Clinical laboratory, 68(1), . https://doi.org/10.7754/Clin.Lab.2021.210507
Kim, Young Jin, et al. "Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea." Clinical laboratory vol. 68,1 (2022). doi: https://doi.org/10.7754/Clin.Lab.2021.210507
Kim YJ, Jung HW, Choi YS, Chang HK, Kim SH, Yeo SG. Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea. Clin Lab. 2022 Jan 01;68(1). doi: 10.7754/Clin.Lab.2021.210507. PMID: 35023671.
Copy Download .nbib Format: NLM
Showing 3121 to 3126 of 3126 entries